Growing Number of Pet Owners Create Sizeable Opportunity for Veterinary Antiseptics Market in APAC, Latin America, and Rest of the World, Says TMR

In veterinary medicine, the recent development of multi-resistant bacteria has necessitated the use of alternative therapeutic approaches for bacterial strains that are practically resistant to all oral antibiotics. The topical use of antimicrobial products such as antiseptics has been recognized as the most simple and effective means for the treatment of multi-resistant bacterial infections on the skin surface. Besides this, the use of local antimicrobial products restricts the spread of bacteria, which in turn, reduces the need for broad-spectrum systemic antibiotics. Typically, in veterinary dermatology, the antiseptic treatment is frequently used as a valid alternative to systemic antibiotic therapy due to several clinical advantages.

View exclusive Global strategic Business report : 
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6448

At present, innovations to keep a check on animal health are crucial to feed the growing global population. To address this, governments across the world need to extend their support for animal health as part of the overall human health policy. Particularly in developing countries such as India, lack of skilled veterinarians and inadequate infrastructure for promoting animal health need attention. These factors will result in the Asia Pacific, Latin America, and Rest of the World veterinary antiseptics market to exhibit a CAGR of 5.6% from 2015 to 2023, says Transparency Market Research.

Q. Is the use of antiseptics defined according to their specific need for animals?

A. Yes. The use of antiseptics for animals is clearly defined as per the degree of infection and the body part that is infected. For example, chlorhexidine is well recognized for its use in oral care. Due to its relatively low degree of irritability to tissues, it is generally used as a bactericidal, fungicidal, and virucidal. Chlorhexidine is majorly used among horses, sheep, poultry animals, cats, cows, and dogs for treating abrasions, superficial cuts, and insect stings.

Q. What are the major forces driving the Asia Pacific, Latin America, and Rest of the World veterinary antiseptics market?

A. The growing demand for animal-based food products in emerging markets, which in turn, is accelerating veterinary care and demand for antiseptic products is one of the major factors driving this market. Moreover, the increasing pet ownership in emerging economies is anticipated to augment demand for companion animal antiseptics.

Q. Which is the leading product segment in the Asia Pacific, Latin America, and Rest of the World market for veterinary antiseptics?

A. Iodine and iodophors held the largest market share in 2014. This is because iodine and iodophors are preferred among veterinarians for production as well as companion animal purposes. In addition, iodine and iodophors are increasingly used since they are milder, which makes them suitable for both small and large animals. Iodophors are used as carriers for iodine for providing a sustained and prolonged release of antiseptics.

Q. What inhibits the use of alcohol-based antiseptic in veterinary practices?

A. Though alcohol is primarily used before vaccination or immunization, particularly in small animals such as dogs, cats, and sheep, alcohol causes a higher degree of irritation on tissues and denatured protein. This could help bacteria to breed in open wounds. Low contact time with the skin of alcohol-based antiseptics due to its early vaporization is a major shortcoming of alcohol-based antiseptics.

Browse Research Report on Global Veterinary Antiseptics Market:
http://www.transparencymarketresearch.com/veterinary-antiseptics-market.html

Veterinary Antiseptics Market to Reach US$401.6 mn by 2023, Propelled by Increasing Applications of Antiseptics

Zoetis, Inc., a global animal health company based in New Jersey, recently completed the construction of a 19,000-square-foot, three-story addition to its production site in the Lincoln province of Nebraska. Zoetis introduced its new product, Canine Atopic Dermatitis Immunotherapeutic, which is an antibody therapy for dogs, targeted at reducing atopic dermatitis. The company also introduced a vaccine that cures PEDv, one of the emerging diseases that recently destroyed pig farms in the U.S. The new plant will facilitate the manufacturing of an injectable hormone, Synovex, which promotes weight gain in cattle. According to the authorities at Zoetis, Inc., the product will be ready to be supplied to customers by 2016. 

Browse Research Report: http://www.transparencymarketresearch.com/veterinary-antiseptics-market.html

Last year, Zoetis was engaged in manufacturing a vaccine to cure porcine epidemic diarrhea virus. The company will expand its animal healthcare services in Lincoln and offer reliable animal health products to livestock suppliers, veterinarians, and pet owners. Zoetis, Inc. will be looking to spread its services with new products that are meant to fulfill the changing market needs and assist veterinarians in improving their approach to animal treatment and disease prevention.  

According to Transparency Market Research, the veterinary antiseptics market in Latin America, Asia Pacific, and Rest of the World stood at US$243.0 mn in 2014 and is expected to reach US$401.6 mn by 2023, at a 5.60% CAGR. 

Iodine and Iodophors Sector to Register Highest Growth

Safer and more effective varieties of antiseptics, used for cleaning the skin and wounds, are being adopted by veterinarians and animal care clinics to treat pets. The veterinary antiseptics market in Latin America, Asia Pacific, and Rest of the World is segmented on the basis of product type into iodine and iodophors, alcohol, chlorhexidine, hydrogen peroxide, and others. In veterinary care, iodine and iodophors are the most commonly used antiseptics. The iodine and iodophors sector accounted for the highest market share in 2014 and is expected to maintain its dominant position by 2023. Iodophors also act as a suitable carrier for iodine and provide prolonged and sustained release of antiseptics. Iodophors and iodine are effective against fungi, bacteria, and viruses. 

Chlorhexidine is commonly used as an antiseptic for common domestic animals such as horse, dogs, cats, cows, sheep, and poultry animals. Alcohol is used before vaccination in small animals including dogs, sheep, and cats. Based on species, veterinary antiseptics market in Latin America, Asia Pacific, and Rest of the World is classified into bovine, porcine, ovine, equine, canine, feline, and camelidae. In terms of consumption trends and population analysis, the bovine antiseptics sector accounted for the highest market share in 2014.

Browse Press Release: http://www.transparencymarketresearch.com/pressrelease/veterinary-antiseptics-market.htm

Introduction of Advanced Antiseptics to Boost Veterinary Antiseptics Market

Strict regulatory guidelines are expected to restrict the growth of the veterinary antiseptics market. However, the introduction of new veterinary antiseptics by the leading market players is predicted to boost the growth prospects of the market during the forecast period. Some of the leading companies in the veterinary antiseptics market in Latin America, Asia Pacific, and Rest of the World are Bayer AG, Elanco Animal Health, Inc., M.B.D. Marketing (S) Pte Ltd., Merial, Vallée S.A, Zoetis, Inc., Continental Manufacturing Chemist, Inc., Indian Immunologicals Ltd., Merck Animal Health, and Nicosia International.